Interferon beta

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from IFN-β)
Jump to: navigation, search

Interferon beta (IFN-β or INF-β) is a type 1 interferon. Interferon beta drugs are immunostimulants, these include interferon beta-1a, interferon beta-1b, and peginterferon beta-1a.[1] There are a number of different interferon alphas, which are also type 1 interferons. Interferon alphas and interferon beta found in humans.[2]

Alternative names[edit | edit source]

Interferon beta is also known as:

  • INF-beta
  • IFN-beta
  • INF-β
  • IFN-β[2]

Drugs[edit | edit source]

Interferon beta-1a is an immunomodulator available under the brand names Avonex Pen, Rebif, and Rebif Rebidose>[3]; interferon beta-1b is sold under the brand name Betaseron (Pro) and Extavia (Pro).[1]Peginterferon beta-1a or pegylated interferon (Peg-IFN) beta-1a is a combination of polyethylene glycol (peg) and interferon beta-1a, and is sold under the brand name Plegridy.[4] All interferon drugs including interferon beta drugs act as immunostimulants.

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.01.1 "List of Interferons". Drugs.com. Retrieved March 9, 2021.
  2. 2.02.1 European Bioinformatics Institute. "Interferon alpha/beta/delta (IPR000471) | InterPro". Retrieved January 24, 2019.
  3. "Peginterferon beta-1a". DrugBank Online. Retrieved March 17, 2021.
  4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876663/

β β / Β. Greek letter beta (symbol), equivalent to "b".

β β / Β. Greek letter beta (symbol), equivalent to "b".

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.